These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29808375)

  • 21. Esophagus or stomach? The seventh TNM classification for Siewert type II/III junctional adenocarcinoma.
    Hasegawa S; Yoshikawa T; Aoyama T; Hayashi T; Yamada T; Tsuchida K; Cho H; Oshima T; Yukawa N; Rino Y; Masuda M; Tsuburaya A
    Ann Surg Oncol; 2013 Mar; 20(3):773-9. PubMed ID: 23224137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment approaches to esophagogastric junction tumors.
    Kurokawa Y; Sasako M; Doki Y
    Dig Surg; 2013; 30(2):169-73. PubMed ID: 23867594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the 7th and 8th Edition of the UICC/AJCC TNM Staging System in Primary Resected Squamous Cell Carcinomas of the Lung-A Single Center Analysis of 354 Cases.
    Neppl C; Keller MD; Scherz A; Dorn P; Schmid RA; Zlobec I; Berezowska S
    Front Med (Lausanne); 2019; 6():196. PubMed ID: 31552253
    [No Abstract]   [Full Text] [Related]  

  • 24. Prognostic differences in 8th edition TNM staging of esophagogastric adenocarcinoma after neoadjuvant treatment.
    Sisic L; Blank S; Nienhüser H; Dorr S; Haag GM; Jäger D; Bruckner T; Müller-Stich BP; Ott K; Büchler MW; Ulrich A; Schmidt T
    Eur J Surg Oncol; 2018 Oct; 44(10):1646-1656. PubMed ID: 30082176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can extracapsular lymph node involvement be a tool to fine-tune pN1 for adenocarcinoma of the oesophagus and gastro-oesophageal junction in the Union Internationale contre le Cancer (UICC) TNM 7th edition?†.
    Nafteux P; Lerut T; De Hertogh G; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P
    Eur J Cardiothorac Surg; 2014 Jun; 45(6):1001-10. PubMed ID: 24477743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic performance of TNM8 staging rules in oral cavity squamous cell carcinoma.
    Jawad H; Ashaari SS; O'Shea R; Callanan D; Sheahan P; Feeley L
    Oral Oncol; 2020 Dec; 111():105021. PubMed ID: 33011675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data.
    Chen J; Xia YJ; Liu TY; Lai YH; Yu JS; Zhang TH; Ooi S; He YL
    BMC Cancer; 2021 May; 21(1):532. PubMed ID: 33971833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenocarcinomas of the esophagogastric junction: experiences at a single institution in China.
    Zhang H; Wang W; Cheng Y; Song Y; Zhu K; Dang C
    World J Surg Oncol; 2013 Jul; 11():155. PubMed ID: 23849250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metrics of pN-staging in oral squamous cell carcinoma: An analysis of 1,905 patients.
    Mirian C; Gerds TA; Pedersen MM; de Ridder M; Balm A; Mattavelli D; Piazza C; Jensen LR; Balasubramanian D; Subramaniam N; Dokhe Y; Thankappan K; Iyer S; Karam SD; Wiegand S; Feeley L; Milross C; Gao K; Palme CE; Low TH; Gupta R; Freudlsperger C; Moratin J; Sheahan P; Clark J; Ovesen T
    Eur J Cancer; 2021 Jun; 150():33-41. PubMed ID: 33887515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of esophago-gastric junction adenocarcinoma.
    de Manzoni G; Zanoni A; Giacopuzzi S
    Ann Ital Chir; 2012; 83(3):208-14. PubMed ID: 22595732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison between site N-category and number N-category for nodal staging in carcinoma of the gastroesophageal junction: our experience and literature review.
    Aurello P; D'Angelo F; Nigri G; Bellagamba R; Cicchini C; Ruzzetti R; Ramacciato G
    Am Surg; 2006 Feb; 72(2):118-23. PubMed ID: 16536239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Personalizing risk stratification by addition of PAK1 expression to TNM staging: improving the accuracy of clinical decision for gastroesophageal junction adenocarcinoma.
    Li Z; Zou X; Xie L; Chen H; Chen Y; Yeung SC; Zhang H
    Int J Cancer; 2015 Apr; 136(7):1636-45. PubMed ID: 25159681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Surgical treatment of gasto-esophageal junction adenocarcinoma: long-term results of a single Italian centre].
    Pedrazzani C; Pasini F; Giacopuzzi S; Bernini M; Ruzzenente A; Festini M; Tomasi I; Cristadoro L; de Manzoni G
    G Chir; 2004 Oct; 25(10):325-33. PubMed ID: 15756954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of the 8th edition of the AJCC yTNM staging system shows improved prognostication in a single center cohort of esophageal carcinomas.
    Kröll D; Noser L; Erdem S; Storni F; Arnold D; Dislich B; Zlobec I; Candinas D; Seiler CA; Langer R
    Surg Oncol; 2018 Mar; 27(1):100-105. PubMed ID: 29549896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
    Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N
    Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in prognosis of Siewert II and III oesophagogastric junction cancers are determined by the baseline tumour staging but not its anatomical location.
    Kulig P; Sierzega M; Pach R; Kolodziejczyk P; Kulig J;
    Eur J Surg Oncol; 2016 Aug; 42(8):1215-21. PubMed ID: 27241921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Siewert III Adenocarcinoma: Still Searching for the Right Treatment Combination.
    Tang A; Sohal D; McNamara M; Murthy SC; Raja S
    Surg Oncol Clin N Am; 2020 Oct; 29(4):647-653. PubMed ID: 32883464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
    Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
    Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma.
    Tokunaga R; Imamura Y; Nakamura K; Uchihara T; Ishimoto T; Nakagawa S; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Oyama S; Shono T; Naoe H; Saeki H; Oki E; Watanabe M; Sasaki Y; Maehara Y; Baba H
    Cancer Med; 2015 Nov; 4(11):1659-66. PubMed ID: 26310928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adenocarcinoma of the esophagogastric junction: retrospective analysis of 39 patients].
    Butte JM; Becker F; Visscher A; Waugh E; Meneses M; Court I; Parada H; DE LA Fuente H
    Rev Med Chil; 2010 Jan; 138(1):53-60. PubMed ID: 20361151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.